We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERNA icon
2751
Eterna Therapeutics
ERNA
$4.02M
$6.44M ﹤0.01%
48
+47
+4,700% +$6.77M
UVE icon
2752
Universal Insurance Holdings
UVE
$1.23B
$6.42M ﹤0.01%
462,848
+4,028
+0.9% +$56.6K
CNTY icon
2753
Century Casinos
CNTY
$36.3M
$6.42M ﹤0.01%
478,170
+15,689
+3% +$205K
KNSA icon
2754
Kiniksa Pharmaceuticals
KNSA
$5.73B
$6.39M ﹤0.01%
458,859
+35,950
+9% +$546K
PRLD icon
2755
Prelude Therapeutics
PRLD
$350M
$6.39M ﹤0.01%
223,252
+24,061
+12% +$857K
GCMG icon
2756
GCM Grosvenor
GCMG
$795M
$6.39M ﹤0.01%
613,301
+265,595
+76% +$3.14M
NVS icon
2757
Novartis
NVS
$292B
$6.39M ﹤0.01%
70,039
+4,528
+7% +$403K
CNBKA
2758
DELISTED
Century Bancorp Inc/Mass
CNBKA
$6.39M ﹤0.01%
56,018
+2,038
+4% +$230K
PAA icon
2759
Plains All American Pipeline
PAA
$17.1B
$6.37M ﹤0.01%
560,436
+9,820
+2% +$101K
SFST icon
2760
Southern First Bancshares
SFST
$601M
$6.36M ﹤0.01%
124,404
+4,652
+4% +$241K
TACO
2761
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$6.35M ﹤0.01%
634,680
+13,235
+2% +$139K
HRMY icon
2762
Harmony Biosciences
HRMY
$2.06B
$6.35M ﹤0.01%
224,942
+124,185
+123% +$3.73M
SENEA icon
2763
Seneca Foods Class A
SENEA
$1.15B
$6.34M ﹤0.01%
124,052
+3,427
+3% +$165K
STGW icon
2764
Stagwell
STGW
$2.13B
$6.32M ﹤0.01%
1,080,819
+572,376
+113% +$2.67M
ATNX
2765
DELISTED
Athenex, Inc. Common Stock
ATNX
$6.32M ﹤0.01%
68,385
+6,372
+10% +$579K
CRCT icon
2766
Cricut
CRCT
$1.01B
$6.32M ﹤0.01%
+148,287
New +$4.16M
PRAX icon
2767
Praxis Precision Medicines
PRAX
$8.52B
$6.29M ﹤0.01%
22,934
+8,923
+64% +$3.2M
CZNC icon
2768
Citizens & Northern Corp
CZNC
$454M
$6.28M ﹤0.01%
256,380
+35,280
+16% +$867K
CCNE icon
2769
CNB Financial Corp
CCNE
$1.05B
$6.24M ﹤0.01%
273,333
+28,400
+12% +$693K
EVC icon
2770
Entravision Communication
EVC
$1.02B
$6.23M ﹤0.01%
932,670
+9,513
+1% +$43K
BPY
2771
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$6.23M ﹤0.01%
328,662
-5,840
-2% -$107K
WTTR icon
2772
Select Water Solutions
WTTR
$2.29B
$6.21M ﹤0.01%
1,028,316
+48,208
+5% +$278K
FPI
2773
Farmland Partners
FPI
$418M
$6.2M ﹤0.01%
514,114
-4,532
-0.9% -$58.2K
LOCO icon
2774
El Pollo Loco
LOCO
$504M
$6.16M ﹤0.01%
336,853
+8,294
+3% +$142K
DJCO icon
2775
Daily Journal
DJCO
$810M
$6.15M ﹤0.01%
18,183
+486
+3% +$156K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.